These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 32491239)

  • 1. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
    Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
    J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
    Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
    Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence.
    Chong H; Gong Y; Zhang Y; Dai Y; Sheng R; Zeng M
    Acad Radiol; 2023 Jan; 30(1):49-63. PubMed ID: 35562264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
    Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
    J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
    Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.
    Peng J; Zhang J; Zhang Q; Xu Y; Zhou J; Liu L
    Diagn Interv Radiol; 2018; 24(3):121-127. PubMed ID: 29770763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-radiomics models based on multi-phase contrast-enhanced magnetic resonance imaging can preoperatively predict glypican-3-positive hepatocellular carcinoma.
    Han Z; Dai H; Chen X; Gao L; Chen X; Yan C; Ye R; Li Y
    Front Physiol; 2023; 14():1138239. PubMed ID: 37601639
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiomic Analysis of Contrast-Enhanced CT Predicts Glypican 3-Positive Hepatocellular Carcinoma.
    Sun S; Xiao S; Jiang Z; Xiao J; He Q; Wang M; Fan Y
    Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38462828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma.
    Zhao J; Gao S; Sun W; Grimm R; Fu C; Han J; Sheng R; Zeng M
    Eur J Radiol; 2021 Jun; 139():109732. PubMed ID: 33905978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
    Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
    J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
    J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of glypican-3 expression in hepatocellular carcinoma using multisequence magnetic resonance imaging-based histology nomograms.
    Li SQ; Yang CX; Wu CM; Cui JJ; Wang JN; Yin XP
    Quant Imaging Med Surg; 2024 Jul; 14(7):4436-4449. PubMed ID: 39022267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
    Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
    J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
    Fan Y; Yu Y; Wang X; Hu M; Hu C
    BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.